0001415889-23-008248.txt : 20230517
0001415889-23-008248.hdr.sgml : 20230517
20230517211109
ACCESSION NUMBER: 0001415889-23-008248
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230516
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mayweg Alexander
CENTRAL INDEX KEY: 0001786260
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39200
FILM NUMBER: 23933549
MAIL ADDRESS:
STREET 1: C/O VERSANT VENTURES, AESCHENVORSTADT 36
CITY: BASEL
STATE: V8
ZIP: 4051
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc.
CENTRAL INDEX KEY: 0001701541
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-417-5868
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Aset Therapeutics, Inc.
DATE OF NAME CHANGE: 20170321
4
1
form4-05182023_010502.xml
X0407
4
2023-05-16
0001701541
Black Diamond Therapeutics, Inc.
BDTX
0001786260
Mayweg Alexander
C/O BLACK DIAMOND THERAPEUTICS, INC.
ONE MAIN STREET, 14TH FLOOR
CAMBRIDGE
MA
02142
true
false
false
false
0
Stock Option (Right to Buy)
1.82
2023-05-16
4
A
0
16500
0
A
2033-05-15
Common Stock
16500
16500
D
The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 16, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
2023-05-17